NEUPRED SYRUP 120ML
Generic: Prednisolone
Pack Size: 120ML
Product Form: Syrup
Delivery within: 2 to 3 working days across Pakistan
₨ 320
-
Official retailer
-
Quality guaranteed
-
Free delivery from $99
-
Free returns is available
Feel comfort with Magisso
Himenaeos parturient nam a justo placerat lorem erat pretium a fusce pharetra pretium enim.
NEUPRED SYRUP 120ML (Prednisolone) is a corticosteroid medication used to treat a variety of conditions, including allergies, asthma, skin conditions, and arthritis. It is available in syrup form and is taken orally. It works by reducing inflammation and suppressing the immune system.
Uses:
NEUPRED SYRUP 120ML (Prednisolone) is used to treat a variety of conditions, including allergies, asthma, skin conditions, and arthritis. It is also used to treat certain types of cancer, such as lymphoma and leukemia. It can also be used to treat certain types of eye conditions, such as uveitis and macular degeneration.
Side Effects:
Common side effects of NEUPRED SYRUP 120ML (Prednisolone) include nausea, vomiting, stomach pain, headache, dizziness, and insomnia. Other side effects may include weight gain, increased appetite, and increased risk of infection.
When Not to Use:
NEUPRED SYRUP 120ML (Prednisolone) should not be used if you are allergic to prednisolone or any of the ingredients in the syrup. It should also not be used if you have a history of tuberculosis, liver or kidney disease, or if you are pregnant or breastfeeding.
Conclusion:
NEUPRED SYRUP 120ML (Prednisolone) is a corticosteroid medication used to treat a variety of conditions, including allergies, asthma, skin conditions, and arthritis. It is available in syrup form and is taken orally. Common side effects include nausea, vomiting, stomach pain, headache, dizziness, and insomnia. It should not be used if you are allergic to prednisolone or any of the ingredients in the syrup, or if you have a history of tuberculosis, liver or kidney disease, or if you are pregnant or breastfeeding.

Reviews
There are no reviews yet.